Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Nature Communications
|
July 27, 2023
Author Correction: Molecular mechanism of phosphopeptide neoantigen immunogenicity
Yury Patskovsky, Aswin Natarajan, Larysa Patskovska, et al.
Journal of Computer-Aided Molecular Design
|
June 13, 2023
OFraMP: a fragment-based tool to facilitate the parametrization of large molecules
Martin Stroet, Bertrand Caron, Martin S Engler, et al.
Nature Communications
|
June 23, 2023
Molecular mechanism of phosphopeptide neoantigen immunogenicity
Yury Patskovsky, Aswin Natarajan, Larysa Patskovska, et al.
Plos One
|
April 5, 2018
Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibody
Randi B Gombos, Ana Gonzalez, Mariana Manrique, et al.
Nature Communications
|
February 6, 2024
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome
Terese C Hammond, Marco A Purbhoo, Sapana Kadel, et al.
Proteins
|
October 25, 2013
Blind prediction of interfacial water positions in CAPRI
Marc F Lensink, Iain H Moal, Paul A Bates, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Nature Communications
|
July 27, 2023
Author Correction: Molecular mechanism of phosphopeptide neoantigen immunogenicity
Yury Patskovsky, Aswin Natarajan, Larysa Patskovska, et al.
Journal of Computer-Aided Molecular Design
|
June 13, 2023
OFraMP: a fragment-based tool to facilitate the parametrization of large molecules
Martin Stroet, Bertrand Caron, Martin S Engler, et al.
Nature Communications
|
June 23, 2023
Molecular mechanism of phosphopeptide neoantigen immunogenicity
Yury Patskovsky, Aswin Natarajan, Larysa Patskovska, et al.
Plos One
|
April 5, 2018
Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibody
Randi B Gombos, Ana Gonzalez, Mariana Manrique, et al.
Nature Communications
|
February 6, 2024
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome
Terese C Hammond, Marco A Purbhoo, Sapana Kadel, et al.
Proteins
|
October 25, 2013
Blind prediction of interfacial water positions in CAPRI
Marc F Lensink, Iain H Moal, Paul A Bates, et al.
Page
of 4